MedPath

Ultravate X

ULTRAVATE X(halobetasol propionate ointment) Ointment, 0.05%For Dermatological Use Only. Not for Ophthalmic Use.Rx only

Approved
Approval ID

21e4e0c0-18c7-480a-af4e-7b553fe8b68c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 8, 2012

Manufacturers
FDA

Ranbaxy Laboratories Inc.

DUNS: 169932519

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Halobetasol Propionate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code10631-119
Application NumberNDA019968
Product Classification
M
Marketing Category
C73594
G
Generic Name
Halobetasol Propionate
Product Specifications
Effective DateNovember 8, 2012
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ultravate X - FDA Drug Approval Details